The prediction of response in the anxiety disorders;Reactiepredictie bij angststoornissen

Acta Neuropsychiatrica

Volumn 8, Issue 4, 1996, Pages 102-105

  Slaap, B R ^a   Van Vliet, I M ^b   Westenberg, H G M ^b   Den Boer, J A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Afdeling Psychiatrie AZU   (Netherlands)

Author keywords

Brofaromine; Fluvoxamine; Panic disorder; Prediction of response; Social phobia

Indexed keywords

BROFAROMINE; FLUVOXAMINE;

ANXIETY; BLOOD PRESSURE; DRUG THERAPY; FEAR; HEART RATE; HUMAN; PHOBIA; PREDICTION; SHORT SURVEY; TREATMENT OUTCOME;

EID: 0030443088     PISSN: 09242708     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0924270800037029     Document Type: Review

References (12)

1. Joyce PR, Paykel ES. Predictors of drug response in depression. Arch gen Psychiat 1989; 46: 89-99.
2. Slaap BR, Boer JA den, Westenberg HGM. De voorspelling van non-respons op farmacotherapie bij paniekstoornis; een overzicht van korte termijn voorspellers. Tijdschr Psychiat 1996; 38: 371-81.
3. Slaap BR, Boer JA den, Westenberg HGM, De voorspelling van non-respons op farmacotherapie bij panickstoornis; een overzicht van lange-termijnvoorspellers. [In Press] Tijdschr Psychiat 1996; in druk.
4. Slaap BR, Vliet IM van, Westenberg HGM, Boer JA den. Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report). J Affect Disord 1995; 33:31-8.
5. Slaap BR, Vliet IM van, Boer JA den, Westenberg HGM. MHPG and heart rate as correlates of non-response to drug therapy in panic disorder patients. Psychopharmacology 1996; in druk.
6. Vliet IM van, Westenberg HGM, Boer JA den. MAO-inhibitors in panic disorder: clinical effects of treatment with brofaromine, a double blind placebo controlled study. Psychopharmacology 1993; 112: 483-9.
7. Vliet IM van, Boer JA den, Westenberg HGM, Slaap BR. A double blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder. J clin Psychopharmacol 1996; in druk.
8. Reich J, Goldenberg I, Goisman R, Vasile R, Keller M. A prospective, follow-along study of the course of social phobia. 2. Testing for basic predictors of course. J nerv ment Dis 1994; 182: 297-301.
9. Versiani M, Mundim FD, Nardi AE, Liebowitz MR. Tranylcypromine in social phobia. J clin Psychopharmacol 1988; 8: 279-83.
10. Slaap BR, Vliet IM van, Westenberg HGM, Boer JA den. Responders and nonresponders to drug treatment in social phobia: Differences at baseline and prediction of response. J affect Disord 1996; 39: 13-9.
11. Vliet IM van, Boer JA den, Westenberg HGM. Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor. Eur Neuropsychopharmacol 1992; 2: 21-9.
12. Vliet IM van, Boer JA den, Westenberg HGM. Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine. Psychopharmacology 1994; 115: 128-34.